Vanderbilt-Nigeria Research Ethics Training (V-NET)
Posted in
Vanderbilt Institute for Global Health (VIGH) and collaborators Aminu Kano Teaching Hospital (AKTH) and Bayero University (BUK) have partnered to establish the Vanderbilt-Nigeria Research Ethics Training Program (V-NET). The program is a comprehensive initiative that encompasses curricular development, didactic coursework, skills development, mentoring, and practicum experiences designed to build capacity for the ethical design, conduct, and oversight of genetic and genomic research in Nigeria.
Vanderbilt-Vietnam Genetic Epidemiology Training Program (V2- GENE)
Posted in
The Vanderbilt Institute for Global Health (VIGH), Hanoi Medical University (HMU), and the Vietnam National Cancer Institute (VNCI) have partnered on a new training program from the Fogarty International Center of the National Institutes of Health. The Vanderbilt-Vietnam Genetic Epidemiology Training Program (V2- GENE) is an initiative to train scholars in the genetic epidemiology of noncommunicable diseases (NCDs).
Vanderbilt-Zambia Cancer Research Training Program (VZCARE)
In partnership with the University of Zambia (UNZA) and the Zambia Cancer Diseases Hospital (CDH), the Vanderbilt Institute for Global Health, the Vanderbilt Epidemiology Center and the Vanderbilt-Ingram Cancer Center received $1.3 million for a five-year training grant funded by the National Cancer Institute to support cancer epidemiology research in Zambia.
Cure Sickle Cell Initiative Data Coordinating Center
Posted in
Project Details: NIH Reporter
Bridging the Childhood Epilepsy Treatment Gap in Northern Nigeria (BRIDGE)
Posted in
Principal Investigator(s):
Muktar Aliyu, M.D., M.P.H., Dr.P.H.
Edwin Trevathan, M.D., M.P.H.
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria
Posted in
Principal Investigator(s):
Muktar Aliyu, M.D., M.P.H., Dr.P.H.
William Wester, M.D., M.P.H.
Bridging the Childhood Epilepsy Treatment Gap in Africa (BRIDGE)
Posted in
Principal Investigator: Edwin Trevathan, MD, MPH
Childhood Status Epilepticus and Epilepsy Determinants of Outcome (SEED)
Posted in
Status epilepticus (SE) is the most common serious neurological emergency among children worldwide. In the low- and middle-income countries (LMICs) of sub-Saharan Africa, the burden of childhood SE-associated mortality and morbidity appears to be especially high. However, the phenotypes of childhood SE, clinical predictors of SE-associated mortality and of SE-associated neurodevelopmental morbidity, and genomic predictors of SE, SE-associated mortality and neurodevelopmental morbidity have not been well-characterized in this region.
UNZA-Vanderbilt Partnership for HIV-NCD Research (UVP-2)
Posted in
The UNZA-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research (UVP-1) and the UNZA-Vanderbilt Partnership for HIV-NCD Research (UVP-2) continue a longstanding training collaboration between the University of Zambia School of Medicine/University Teaching Hospital (UNZA/UTH), Vanderbilt University (VU) and the Vanderbilt Institute for Global Health (VIGH).
Improving Perioperative Anesthesia Care and Training in Africa (ImPACT Africa)
Posted in
The Improving Perioperative Anesthesia Care and Training in Africa (ImPACT Africa) program addresses the critical need for safe surgery by training local anesthesia providers and building educational capacity of local institutions. Vanderbilt Institute for Global Health (VIGH) faculty members, Marie Martin and Elizabeth Rose, along with other VIGH staff and student collaborators, have partnered with ImPACT Africa leaders to provide education consulting and develop new courses.
Etiology of Persistent Microalbuminuria in Nigeria
Posted in
The Vanderbilt Institute for Global Health (VIGH) and Aminu Kano Teaching Hospital (AKTH) in Kano, Nigeria have received a federal grant to study the factors associated with microalbuminuria among participants in an ongoing clinical trial of genetically at-risk HIV-positive adult Nigerians.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant will provide $2.2 million over the next four years.
Management of severe acute malnutrition in children with sickle cell disease greater than 5 years of age living in northern Nigeria
Posted in
Project Details: NIH Reporter
Abstract Text